Clinical trial
Palbociclib in Real World Practice
NCT03280303
Study timeline
Study start (actual)2017-01-04Date precision: day
Registry last updated2024-09-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Breast Cancerunresolved
Metastatic Breast Cancerunresolved
Interventions
non-interventionalOTHER
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
BirminghamAlabama, United States7JacksonvilleFlorida, United States7St LouisMissouri, United States6Baton RougeLouisiana, United States4MiamiFlorida, United States3San AntonioTexas, United States3Fort WorthTexas, United States3Saint PaulMinnesota, United States3SavannahGeorgia, United States3Saint Louis ParkMinnesota, United States3HoustonTexas, United States2BaltimoreMaryland, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03280303 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.